ロード中...
The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
BACKGROUND: The outcome of chemotherapy in breast cancer is strongly influenced by multidrug resistance (MDR). Several surrogate markers of chemoresistance have been identified including - CD24 (cluster differentiation 24) expression, stem cell growth factor (SCF), B-cell lymphocyte protein 2 (Bcl-2...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3413589/ https://ncbi.nlm.nih.gov/pubmed/22642642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-12-21 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|